Xeljanz
Xeljanz is a brand name for tofacitinib, a medication used to treat certain autoimmune conditions. It belongs to a class of drugs called Janus kinase (JAK) inhibitors. JAK inhibitors work by blocking the activity of Janus kinases, which are enzymes involved in the signaling pathways of immune cells that cause inflammation. By reducing this inflammation, Xeljanz can help alleviate symptoms associated with certain chronic inflammatory diseases.
Xeljanz is primarily prescribed for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative
Like all medications, Xeljanz can cause side effects. Common side effects may include upper respiratory tract